Significant Ownership of Point72 Asset Management, L.P.

Notable people
Steven A. Cohen
Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Point72 Asset Management, L.P. focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Jason M. Colombo - Jason M. Colombo, Authorized Person
Manager location
Stamford, CT

Follow Filing Activity

Follow Point72 Asset Management, L.P. with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Significant Ownership of Point72 Asset Management, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CYBN CYBIN INC. Common Shares, no par value 9.9% $37,759,482 +$28,298,275 6,410,778 +299% Point72 Asset Management, L.P. 30 Sep 2025
PTNT PALATIN TECHNOLOGIES INC Common Stock, par value $0.01 per share 9.9% $23,646,750 2,307,000 Point72 Asset Management, L.P. 12 Nov 2025
TNXP Tonix Pharmaceuticals Holding Corp. Common Stock, par value $0.001 per share 9.2% $19,884,434 1,235,058 Point72 Asset Management, L.P. 29 Dec 2025
ONCH 1RT Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share 8.7% 1,500,000 Point72 Asset Management, L.P. 03 Jul 2025
ANGO AngioDynamics, Inc. Common Stock, par value $0.01 per share 7.7% $36,177,396 +$7,077,143 3,181,829 +24% Point72 Asset Management, L.P. 31 Mar 2026
ATRA Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 7.6% $6,712,128 687,718 Point72 Asset Management, L.P. 30 Jun 2026
TNXP Tonix Pharmaceuticals Holding Corp. Common Stock, par value $0.001 per share 6.9% $165,145 1,100,964 Point72 Asset Management, L.P. 31 Mar 2026
VNET VNET Group, Inc. Class A Ordinary Shares, par value $0.00001 per share 6.6% $881,014,822 +$241,425,709 109,989,366 +38% Point72 Asset Management, L.P. 30 Jun 2026
AIB AIB Data Centers Inc. Common Stock, par value $0.0001 per share 6.6% $9,131,182 +$1,954,083 4,989,717 +27% Point72 Asset Management, L.P. 30 Jun 2026
PSIX Power Solutions International, Inc. Common Stock, par value $0.001 per share 6.5% $51,996,193 +$11,856,509 1,497,155 +30% Point72 Asset Management, L.P. 30 Jun 2026
FBRX Forte Biosciences, Inc. Common Stock, par value $0.001 per share 6.3% $21,132,810 792,976 Point72 Asset Management, L.P. 12 Jan 2026
GLTO Galecto, Inc. Common Stock, par value $0.00001 per share 6.3% $372,164 100,001 Point72 Asset Management, L.P. 12 Nov 2025
ATRA Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 6.2% 526,682 Point72 Asset Management, L.P. 07 May 2026
RXST RxSight, Inc. Common Stock, par value $0.001 per share 6% $13,407,453 2,487,468 Point72 Asset Management, L.P. 12 Aug 2026
Infinite Eagle Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share 5.8% 1,760,000 Point72 Asset Management, L.P. 20 Jan 2026
STRO SUTRO BIOPHARMA, INC. Common Stock, par value $0.001 per share 5.7% $23,590,623 946,829 Point72 Asset Management, L.P. 24 Apr 2026
PCSC Perceptive Capital Solutions Corp Class A Ordinary Shares, par value $0.0001 per share 5.7% $5,240,550 465,000 Point72 Asset Management, L.P. 07 Jul 2026
MSGE Madison Square Garden Entertainment Corp. Class A Common Stock, par value $0.01 per share 5.5% $72,797,952 2,239,248 Point72 Asset Management, L.P. 31 Dec 2024
SRZN Surrozen, Inc./DE Common Stock, par value $0.0001 per share 5.4% $16,908,020 615,957 Point72 Asset Management, L.P. 22 Apr 2026
EVMN Evommune, Inc. Common Stock, par value $0.0001 per share 5.3% $25,391,927 1,910,489 Point72 Asset Management, L.P. 15 Jul 2026
PGEN PRECIGEN, INC. Common Stock, no par value per share 5.2% $76,841,952 18,383,242 Point72 Asset Management, L.P. 22 Jan 2026
STAA STAAR Surgical Company Common Stock, par value $0.01 per share 5.2% $69,555,806 2,591,498 Point72 Asset Management, L.P. 11 May 2026
AVTX Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share 5.2% $35,782,784 +$27,499,758 2,710,817 +332% Point72 Asset Management, L.P. 22 May 2026
BBNX Beta Bionics, Inc. Common Stock, par value $0.0001 per share 5.2% $34,190,043 2,290,023 Point72 Asset Management, L.P. 18 Feb 2026
BILL BILL Holdings, Inc. Common Stock, par value $0.00001 per share 5% $247,450,711 5,035,627 Point72 Asset Management, L.P. 21 Nov 2025
VRDN Viridian Therapeutics, Inc. Common Stock, par value $0.01 per share 5% $110,963,262 5,687,507 Point72 Asset Management, L.P. 19 Aug 2026
RUN Sunrun Inc. Common Stock, par value $0.0001 per share 5% $78,798,749 11,503,467 Point72 Asset Management, L.P. 26 Jun 2025
STIM Neuronetics, Inc. Common Stock, par value $0.01 per share 5% $6,841,602 3,822,124 Point72 Asset Management, L.P. 13 Aug 2026
QTTB Q32 Bio Inc. Common Stock, par value $0.0001 per share 5% $25,087,206 +$4,588,747 1,173,396 +22% Point72 Asset Management, L.P. 30 Jun 2026
LENZ LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share 4.8% $63,244,042 1,357,751 Steven A. Cohen 30 Sep 2025
REPL Replimune Group, Inc. Common Stock, par value $0.001 per share 4.7% $15,209,289 -$3,488,586 3,629,902 -19% Point72 Asset Management, L.P. 30 Sep 2025
LLYVA Liberty Media Corp Series A Liberty Live Common Stock, par value $0.01 per share 4.6% $77,347,262 1,164,693 Point72 Asset Management, L.P. 31 Dec 2024
VTYX Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share 4.5% $9,981,996 -$8,351,669 3,209,645 -46% Point72 Asset Management, L.P. 30 Sep 2025
BRCB Black Rock Coffee Bar, Inc. Class A Common Stock, par value $0.00001 per share 4.3% $11,214,692 -$2,859,787 755,707 -20% Point72 Asset Management, L.P. 31 Mar 2026
KALV KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 4.2% $42,995,233 -$12,976,635 2,136,940 -23% Point72 Asset Management, L.P. 31 Mar 2026
RCUS Arcus Biosciences, Inc. Common Stock, par value $0.0001 per share 4.1% $58,921,714 -$20,381,232 4,332,479 -26% Point72 Asset Management, L.P. 30 Sep 2025
COGT Cogent Biosciences, Inc. Common Stock, par value $0.001 per share 4% $82,625,042 -$60,775,814 5,753,833 -42% Point72 Asset Management, L.P. 30 Sep 2025
ADCT ADC Therapeutics SA Common Shares, par value CHF 0.08 per share 4% $18,554,083 -$10,422,190 5,014,617 -36% Point72 Asset Management, L.P. 31 Dec 2025
ALTS ALT5 Sigma Corp Common Stock, par value $0.001 per share 4% 4,872,756 Point72 Asset Management, L.P. 11 Aug 2025
STNE StoneCo Ltd. Class A Common Shares, par value US$0.000079365 per share 3.9% $154,268,604 -$64,018,202 9,972,114 -29% Point72 Asset Management, L.P. 30 Jun 2025
BCYC BICYCLE THERAPEUTICS PLC Ordinary Shares, nominal value 0.01 GBP per share 3.9% $14,882,536 -$15,032,008 1,860,317 -50% Point72 Asset Management, L.P. 30 Jun 2025
PAGS PagSeguro Digital Ltd. Class A Common Shares, par value $0.000025 per share 3.8% $57,737,749 -$40,080,797 5,989,393 -41% Point72 Asset Management, L.P. 31 Dec 2025
DSGN Design Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.8% $37,011,325 -$13,001,704 2,366,453 -26% Point72 Asset Management, L.P. 30 Jun 2026
WOLF WOLFSPEED, INC. Common Stock, par value $0.00125 per share 3.8% $19,317,826 -$10,844,380 990,150 -36% Point72 Asset Management, L.P. 31 Dec 2025
ANRO Alto Neuroscience, Inc. Common Stock, par value $0.0001 per share 3.7% $25,384,353 -$35,845,929 1,170,865 -59% Steven A. Cohen 31 Mar 2026
CTMX CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share 3.6% $28,900,822 -$11,298,128 7,811,033 -28% Point72 Asset Management, L.P. 30 Jun 2026
TDOC Teladoc Health, Inc. Common Stock, par value $0.001 per share 3.3% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025
JANX Janux Therapeutics, Inc. Common Stock, par value $0.001 per share 3.3% $32,200,468 -$17,376,140 1,993,837 -35% Point72 Asset Management, L.P. 30 Jun 2026
SG Sweetgreen, Inc. Class A Common Stock, par value $0.001 per share 3.3% $28,972,928 -$25,791,153 3,503,377 -47% Point72 Asset Management, L.P. 30 Jun 2026
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.3% $13,539,819 +$7,071 5,964,678 +0.05% Point72 Asset Management, L.P. 31 Mar 2026
ATYR aTYR PHARMA INC Common Stock, par value $0.001 per share 3.2% $9,617,297 2,845,354 Point72 Asset Management, L.P. 31 Mar 2025
TENX TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 3.1% $7,988,116 +$1,653,828 533,965 +26% Point72 Asset Management, L.P. 31 Mar 2026
PEPG PepGen Inc. Common Stock, par value $0.0001 per share 3% $9,551,949 -$2,811,415 2,067,432 -23% Point72 Asset Management, L.P. 30 Sep 2025
DRUG BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value 3% $4,175,988 135,189 Point72 Asset Management, L.P. 31 Dec 2024
MBLY Mobileye Global Inc. Class A Common Stock, par value $0.01 per share 2.8% $84,823,217 -$3,371,672 6,007,310 -3.8% Point72 Asset Management, L.P. 30 Sep 2025
TSEM TOWER SEMICONDUCTOR LTD Ordinary Shares, par value NIS 15.00 per share 2.6% $206,369,650 -$252,010,688 2,854,352 -55% Point72 Asset Management, L.P. 30 Sep 2025
CLDX Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share 2.6% $43,255,582 -$66,568,658 1,758,357 -61% Point72 Asset Management, L.P. 31 Dec 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.6% $38,074,233 -$26,039,432 2,801,636 -41% Point72 Asset Management, L.P. 30 Sep 2025
ENTX Entera Bio Ltd. Ordinary shares, par value NIS 0.0000769 per share 2.6% $2,271,583 -$2,915,412 1,183,116 -56% Point72 Asset Management, L.P. 30 Sep 2025
LION Lionsgate Studios Corp. Common Shares, no par value per share 2.4% $72,826,821 -$83,242,966 6,844,626 -53% Point72 Asset Management, L.P. 31 Mar 2026
RPD Rapid7, Inc. Common Stock, par value $0.01 per share 2.4% $36,462,076 1,502,971 Point72 Asset Management, L.P. 31 Dec 2024
SNDX Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share 2.3% $46,382,378 -$54,718,581 1,985,547 -54% Point72 Asset Management, L.P. 31 Mar 2026
OLMA Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.3% $7,781,412 1,543,931 Point72 Asset Management, L.P. 31 Mar 2025
IDYA IDEAYA Biosciences, Inc. Common Stock, par value $0.0001 per share 2.1% $67,953,443 -$94,600,552 1,844,556 -58% Point72 Asset Management, L.P. 31 Dec 2025
ARRY Array Technologies, Inc. Common Stock, par value $0.001 per share 2% $16,159,114 -$24,118,877 3,054,653 -60% Point72 Asset Management, L.P. 31 Mar 2025
GLTO Damora Therapeutics, Inc. Common Stock, par value $0.00001 per share 2% 1,193,708 Point72 Asset Management, L.P. 31 Mar 2026
XON PRECIGEN, INC. Common Stock, no par value per share 1.9% 6,741,861 Point72 Asset Management, L.P. 31 Mar 2026
VERA Vera Therapeutics, Inc. Class A Common Stock, par value $0.001 per share 1.7% $51,344,964 1,229,525 Point72 Asset Management, L.P. 25 Mar 2026
WWW Wolverine World Wide Inc /DE/ Common Stock, par value $1 per share 1.5% $22,858,695 -$71,449,297 1,230,285 -76% Point72 Asset Management, L.P. 31 Dec 2025
DYN Dyne Therapeutics, Inc. Common Stock, par value $0.0001 per share 1.5% $18,546,390 -$39,187,803 1,669,342 -68% Point72 Asset Management, L.P. 31 Mar 2025
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 1.4% $99,621,000 -$249,731,915 450,000 -71% Point72 Asset Management, L.P. 31 Dec 2025
STRO SUTRO BIOPHARMA, INC. Common Stock, par value $0.001 per share 1.4% $7,284,641 237,827 Point72 Asset Management, L.P. 30 Jun 2026
CYBN CYBIN INC. Common Shares, no par value 1.4% 686,669 Point72 Asset Management, L.P. 31 Mar 2026
LITE Lumentum Holdings Inc. Common Stock, par value $0.001 per share 1.3% $83,269,755 -$307,562,007 895,470 -79% Point72 Asset Management, L.P. 30 Jun 2025
VSTM Verastem, Inc. Common Stock, par value $0.0001 per share 1.3% $7,681,601 -$18,090,994 995,026 -70% Point72 Asset Management, L.P. 31 Dec 2025
OVID Ovid Therapeutics Inc. Common Stock, par value $0.001 per share 1.3% $5,483,356 -$13,891,006 1,903,943 -72% Point72 Asset Management, L.P. 31 Mar 2026
DNTH Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share 1.2% $58,992,284 -$214,307,954 643,599 -78% Point72 Asset Management, L.P. 31 Mar 2026
KOD Kodiak Sciences Inc. Common Stock, par value $0.0001 per share 1% $15,342,719 -$39,177,215 609,806 -72% POINT72 ASSET MANAGEMENT, L.P. 26 Mar 2026
SPHR Sphere Entertainment Co. Class A Common Stock, par value $0.01 per share 0.8% $13,881,584 -$81,500,570 223,464 -85% Point72 Asset Management, L.P. 30 Sep 2025
PTNT PALATIN TECHNOLOGIES INC Common Stock, par value $0.01 per share 0.5% $1,462 8,600 Point72 Asset Management, L.P. 31 Mar 2026
RGLS Regulus Therapeutics Inc. Common Stock, par value $0.001 per share 0.3% $1,977,487 -$30,197,722 241,157 -94% Point72 Asset Management, L.P. 30 Jun 2025
ANAB ANAPTYSBIO, INC Common Stock, par value $0.001 per share 0.2% $3,137,339 -$131,220,291 55,303 -98% Point72 Asset Management, L.P. 31 Mar 2026
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 0.2% $720,601 -$17,646,090 411,772 -96% Point72 Asset Management, L.P. 31 Mar 2026
CCCC C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share 0.2% $429,504 -$57,095,520 169,096 -99% Point72 Asset Management, L.P. 31 Mar 2026
CFLT Confluent, Inc. Class A Common Stock, par value $0.00001 per share 0.1% $5,589,991 -$527,903,079 183,700 -99% Point72 Asset Management, L.P. 31 Dec 2025
ANNX Annexon, Inc. Common Stock, par value $0.001 per share 0.1% $181,317 95,430 Point72 Asset Management, L.P. 31 Mar 2025
PLRX PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 0.1% $56,775 -$4,926,946 46,537 -99% Point72 Asset Management, L.P. 31 Dec 2025
IVVD Invivyd, Inc. Common Stock, par value $0.0001 per share 0% $75,561 -$28,567,661 43,931 -100% Point72 Asset Management, L.P. 31 Mar 2026
WHWK Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $7,834 -$2,256,445 5,087 -100% Point72 Asset Management, L.P. 31 Mar 2025
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 0% $393 -$717,340 257 -100% Point72 Asset Management, L.P. 30 Sep 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 0% $14.88 496 Point72 Asset Management, L.P. 31 Dec 2024
EDSA Edesa Biotech, Inc. Common Shares, without par value 0% $11.8 -$3,539,988 2 -100% Point72 Asset Management, L.P. 31 Mar 2026
FGNX FG Nexus Inc. Common Stock, par value $0.001 per share 0% $0 -$12,960,000 0 -100% Point72 Asset Management, L.P. 31 Dec 2025
TSBX Turnstone Biologics Corp. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. 30 Sep 2025
IBIO iBio, Inc. Common Stock, par value $0.001 per share 0% $0 -$31,436,060 0 -100% Point72 Asset Management, L.P. 31 Mar 2026
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$67,280,000 0 -100% Point72 Asset Management, L.P. 31 Mar 2026
ORIC Oric Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0% $0 -$45,777,254 0 -100% Point72 Asset Management, L.P. 31 Mar 2026
RLAY Relay Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 -$201,685,560 0 -100% Point72 Asset Management, L.P. 31 Mar 2026
IOBTQ IO Biotech, Inc. Common Stock, par value $0.001 per share 0% $0 -$40,271 0 -100% Point72 Asset Management, L.P. 31 Mar 2026
CDMO Avid Bioservices, Inc. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. 31 Dec 2024

Schedules 13D/G Reported by Point72 Asset Management, L.P.:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .